Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia (2006)
- Authors:
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP
- Unidade: FMRP
- Subjects: CANNABIS (EFEITOS); ANSIEDADE (TRATAMENTO); ESQUIZOFRENIA
- Language: Inglês
- Imprenta:
- Publisher: Studium Press
- Publisher place: Houston
- Date published: 2006
- ISBN: 0-9656038-5-7
- Source:
- Título do periódico: Recent progress in medicinal plants: biopharmaceuticals
-
ABNT
ZUARDI, Antonio Waldo et al. Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia. Recent progress in medicinal plants: biopharmaceuticals. Tradução . Houston: Studium Press, 2006. . . Acesso em: 19 abr. 2024. -
APA
Zuardi, A. W., Crippa, J. A. de S., Hallak, J. E. C., Moreira, F. A., Aguiar, D. C., & Guimarães, F. S. (2006). Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia. In Recent progress in medicinal plants: biopharmaceuticals. Houston: Studium Press. -
NLM
Zuardi AW, Crippa JA de S, Hallak JEC, Moreira FA, Aguiar DC, Guimarães FS. Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia. In: Recent progress in medicinal plants: biopharmaceuticals. Houston: Studium Press; 2006. [citado 2024 abr. 19 ] -
Vancouver
Zuardi AW, Crippa JA de S, Hallak JEC, Moreira FA, Aguiar DC, Guimarães FS. Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia. In: Recent progress in medicinal plants: biopharmaceuticals. Houston: Studium Press; 2006. [citado 2024 abr. 19 ] - Effects of minocycline on regional cerebral blood flow in schizophrenia
- Canabidiol: possíveis aplicacões terapêuticas em psicopatologias
- A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
- Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug
- Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder
- Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
- Cannabidiol: an anxiolytic or an antipsychotic new drug?
- Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
- Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update
- Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
